Chargement en cours...
Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancer
The epidermal growth factor receptor (EGFR) is a promising therapeutic target in non-small cell lung cancer, and several therapeutic agents that target this receptor, including EGFR tyrosine kinase inhibitors and monoclonal antibodies to EGFR, have been developed. Such monoclonal antibodies have sho...
Enregistré dans:
| Publié dans: | Lung Cancer (Auckl) |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5312480/ https://ncbi.nlm.nih.gov/pubmed/28210119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S16440 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|